Federico Grossi - Jun 28, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Stock symbol
APLS
Transactions as of
Jun 28, 2021
Transactions value $
$33,840
Form type
4
Date filed
6/29/2021, 04:58 PM
Previous filing
Jun 15, 2021
Next filing
Jul 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $33.8K +9K +16.38% $3.76* 63.9K Jun 28, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -9K -38.04% $0.00 14.7K Jun 28, 2021 Common Stock 9K $3.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on February 8, 2016 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.